REGN logo
Regeneron Pharmaceuticals, Inc.(REGN)
Last print unknown agoAbout this dataData status
$782.04▼-8.70 (-1.10%)Stale · unknown oldEarnings · Oct 30

REGN CapEx to Operating CF

20.73%TTM

Retrieved:

REGN FY CapEx/OCF%
REGN FY CapEx/OCF173.91%-553.99%
1990-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

REGN capex to operating cf history

Capital expenditure as percentage of operating cash flow. The available annual fiscal periods series contains 36 observations from Dec 31, 1990 to Dec 31, 2025.

Regeneron Pharmaceuticals CapEx to Operating CF — Annual fiscal periods
Period endingCapEx to Operating CF
18.0441%
17.0999%
20.1654%
11.7669%
7.7938%
23.475%
17.679%
17.4525%
20.8553%
34.4505%
50.9425%
44.2571%
26.5586%
-66.1221%
-40.3841%
103.4719%
-134.7335%
-39.1274%
67.39%
12.182%
-16.385%
-36.5131%
-483.548%
-31.0976%
-14.3458%
-23.2712%
-41.3043%
-29.4118%
-34.4262%
-42.3645%
-18.1319%
-33.6585%
-33.887%
-12.2093%
-14.7059%
0%

Compare capex to operating cf

All REGN financial metrics · REGN stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.